SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?


To: GREENLAW4-7 who wrote (39400)3/12/2002 9:10:18 AM
From: Frederick Langford  Respond to of 99280
 
Myriad Genetics enters drug discovery pact with Abbott (MYGN) 36.05: Forms discovery collaboration with Abbott Laboratories (ABT) to identify novel genes and drug targets for the diagnosis and treatment of depression. The agreement provides Abbott with license rights and specifies an upfront payment to Myriad, plus guaranteed research funding and potential milestones totaling approx. $34 mln plus royalties.

Fred